| 注册
首页|期刊导航|国际医药卫生导报|荆花胃康胶丸与雷贝拉唑、多潘立酮联合治疗反流性食管炎的疗效观察

荆花胃康胶丸与雷贝拉唑、多潘立酮联合治疗反流性食管炎的疗效观察

陈健 韦文明 严衍伟 甘少光 廖鑑能

国际医药卫生导报2013,Vol.19Issue(14):2116-2118,3.
国际医药卫生导报2013,Vol.19Issue(14):2116-2118,3.DOI:10.3760/cma.j.issn.1007-1245.2013.14.014

荆花胃康胶丸与雷贝拉唑、多潘立酮联合治疗反流性食管炎的疗效观察

Curative effect observation on Jinghua Weikang capsules and rabeprazole, domperidone of combination therapy in the treatment of reflux esophagitis

陈健 1韦文明 2严衍伟 1甘少光 1廖鑑能1

作者信息

  • 1. 526040 肇庆市第一人民医院内科
  • 2. 526040 肇庆市第一人民医院中医科
  • 折叠

摘要

Abstract

Objective To observe the curative effect of Jinghua Weikang capsules combined with Rabeprazole and Domperidone combination therapy in the treatment of reflux esophagitis.Methods 288 cases of reflux esophagitis were randomly assigned into observation group (144 cases) and control group (144 cases).The control group was treated with Rabeprazole sodium enteric-coated capsules 10 mg,twice a day; Domperidone tablets 10 mg,3 times a day.Both tablets were taken half an hour before meals.Compared to treatment measure in control group,the observation group was added with Jinghua Weikang capsules 160 mg,3 times a day,lasting for 8 weeks.Then we compared two group patients' clinical symptoms and improvement in endoscopic appearance after treatment.Results Clinical effective rate in observation group was 89.6 % (129/144),clinical effective rate in control group was 60.4% (87/144).Endoscopic esophagitis healing and inflammation improving situation:observation group 97.1% (132/144),control group 64.6% (93/144),both were significantly different (P<0.05).Conclusion Jinghua Weikang capsules combined with Rabeprazole and Domperidone has good curative effect in the treatment of reflux esophagitis.

关键词

荆花胃康胶丸/雷贝拉唑钠肠溶胶囊/多潘立酮/反流性食管炎

Key words

Jinghua Weikang capsules/Rabeprazole sodium enteric-coated capsules/Domperidone/Reflux Esophagitis

引用本文复制引用

陈健,韦文明,严衍伟,甘少光,廖鑑能..荆花胃康胶丸与雷贝拉唑、多潘立酮联合治疗反流性食管炎的疗效观察[J].国际医药卫生导报,2013,19(14):2116-2118,3.

国际医药卫生导报

1007-1245

访问量0
|
下载量0
段落导航相关论文